Apr 16, 2012 13:52 CEST
Feb 29, 2012 15:30 CET Cavidi has moved to a new facility in Uppsala due to a rapid increase in market demand for their ExaVir Load HIV drug monitoring product. The facility is built to suit Cavidi's needs for multiple new R&D projects and production scale up. "The flexible, modular design of the space allows for unlimited future expansion and was the key to site selection" said CEO John Reisky de Dubnic.
Jun 05, 2008 16:14 CEST
Atlanta – CNN broadcasted a feature piece on Cavidi’s ExaVir Load HIV viral load assay. The story centered on Cavidi’s mission to make essential medical diagnostics accessible to patients in every part of the world. Specifically, it tells the story of how the Swedish company designed an HIV viral load assay that can be implemented in resource-limited settings.